PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-Nov-2020 Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases Lead Pharma
16-Nov-2020 FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease Sanofi
16-Nov-2020 Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status AstraZeneca 
16-Nov-2020 Full results from AFFIRM-AHF study show Ferinject® significantly reduces hospitalizations after acute heart failure in patients with iron deficiency Vifor Pharma
15-Nov-2020 Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate Johnson & Johnson
13-Nov-2020 Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library Medidata
13-Nov-2020 Sareum Provides Update on Licensing Agreement Regarding SRA737, a Chk1 inhibitor in Clinical Development Targeting Solid Cancers Sareum Holdings plc
12-Nov-2020 Pioneering research detects Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) discovered in Prostate Cancer APIS Assay Technologies Ltd
12-Nov-2020 Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology Isohelix
12-Nov-2020 Cardior Pharmaceuticals Announces Positive Phase Ib Results of its Lead Compound CDR132L in Heart Failure Cardior Pharmaceuticals
11-Nov-2020 Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate Medicago
11-Nov-2020 Data showing SARS-CoV-2 reactive T cells are associated with protection from COVID-19 – and can be both detected and measured using Oxford Immunotec’s T-SPOT®technology - is published by Public Health England and Oxford Immunotec Oxford Immunotec Global PLC
10-Nov-2020 PharmiWeb.Jobs Welcomes Marketplace Technical PharmiWeb.Jobs
10-Nov-2020 Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma Genmab
10-Nov-2020 Lonza Announces Broad Selection of High-Resolution HLA-typed Primary Cell Lots to Support Biologic Drug Research Lonza Group AG
10-Nov-2020 Agenus Doses First COVID-19 Patient with iNKT Cell Therapy Agenus Inc.
09-Nov-2020 Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective Pfizer
05-Nov-2020 Medigene AG: Oral and poster presentations on Medigene's clinical research at ASH conference Medigene AG
05-Nov-2020 Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma Genmab
05-Nov-2020 Chi-Med Highlights HMPL-689 Clinical Data to be Presented at the 62nd ASH Annual Meeting Chi-Med